Full Course: 10 ADA CERP/AGD PACE Credits (PRD 5/25/18, EXP 5/24/21)for CE/CPD (Code 340) or 16 for California Board of Dental Examiners (CBDE) for CD/CPD Credits
Courses are appropriate for: General Dentists, Oral Surgeons, Endodontists, Geriatric Dental Specialists, Dental Implant Surgeons, Prosthodontists, Dental Assistants and Dental Hygienists
200 Most Common Drugs (DRG2) Topics Include: Cardiovascular Drugs, Drugs for Thromboembolic Complications, Endocrine Drugs, Diabetes Medications, Thyroid Dysfunction, Adrenal Function, Osteopenia & Osteoporosis, and more.
To view topic outline of the full course, select the Course Type (Full) below:
Dr. Geza T. Terezhalmy received his D.D.S. degree from Case Western Reserve School of Dental Medicine and his M.A. from The George Washington University. Currently he is a professor for the Department of Comprehensive Dentistry at the University of Texas Health Science Center at the San Antonio Dental School. He is also a clinical professor for the Department of Pharmacology at the Graduate School of Biomedical Sciences at the University of Texas Health Science Center at the San Antonio Dental School. Dr. Terezhalmy serves as a National Consultant for Dental Pharmacotherapeutics to the US Surgeon General and also to the Naval Postgraduate Dental School as a consultant in their department of Oral Medicine. He has served on the editorial boards of Quintessence International, Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology and has an extensive list of publication credits with articles appearing in The American Journal of Dentistry, The International Journal of Dental Hygiene, the Journal of Contemporary Dental Practice and the Archives of Oral Biology. Dr. Terezhalmy has served as president of the Organization of Teachers of Oral Diagnosis and of the American Academy of Oral Medicine.
Endocrine Drugs
Diabetes Medications
Drugs for Thyroid Dysfunction
Drugs for Adrenal Function
Drugs for Osteopenia & Osteoporosis
Diabetes Medications
Drugs for Thyroid Dysfunction
Drugs for Adrenal Function
Drugs for Osteopenia & Osteoporosis
Course Objectives
Today’s clinicians treat more medically and pharmacologically compromised patients than ever before. The availability of more than a thousand active ingredients in several thousand different formulations, and with over 100,000 nonprescription medications, with hundreds of facts about each of them, presents a seemingly insurmountable challenge in mastering the essentials for the clinical decision making process. Fortunately, the clinician who understands general pharmacological principles can learn to predict the behavior of each drug based on a few facts. It is better to develop a drug profile than it is to memorize isolated data. The best way to achieve this objective is to associate, envision, predict, and inquire.
Associate each drug with information already know
Envision the course of events that would occur as a drug enters the patient’s body
Predict clinical uses and adverse drug effects based on a drug’s mechanism of action
Inquire which fact about a drug is going to impact on the clinical decision making process
GENERAL OBJECTIVES
Participants in this course will be introduced to representative cardiovascular drug profiles based on the top 200 drugs dispensed by U.S. community pharmacies. An awareness of the various drugs commonly prescribed drugs will assist clinicians in identifying patients with commonly encountered cardiovascular problems. The intent is to provide participants with evidence-based knowledge essential for risk stratification of patients taking cardiovascular drugs and the development of appropriate diagnostic, preventive, and therapeutic strategies commensurate with a patient’s ability to undergo and respond to dental care.
LEARNING OUTCOMES
After completing this course the participant will have a better understanding and working knowledge of the following:
Evidence-based knowledge essential for risk stratifications of patients taking one of 200 drugs dispensed by United States community pharmacies and for the developing oral healthcare strategies commensurate with patients’ functional capacity.
Discuss the medical management of common systemic diseases predicated on the top 200 prescription drugs
Discuss disease-related, treatment-related and procedure-related variables
Develop therapeutic strategies predicated on the patient’s ability to undergo and respond to dental care
Accreditation
American Seminar Institute is an approved provider of ADA-CERP, AGD-PACE and the California Board of Dental Examiners.
Produced: 5/25/2018 Expires for ADA/AGD Credit: 5/24/2021
For up-coming courses, please visit: Dental Courses Coming Soon. There you will find abbreviated listings of additional courses that are soon to be released.
200 Most Common Drugs Seminar (DRG2)
Full Course: 10 ADA CERP/AGD PACE Credits (PRD 5/25/18, EXP 5/24/21) for CE/CPD (Code 340) or 16 for California Board of Dental Examiners (CBDE) for CD/CPD Credits
Courses are appropriate for: General Dentists, Oral Surgeons, Endodontists, Geriatric Dental Specialists, Dental Implant Surgeons, Prosthodontists, Dental Assistants and Dental Hygienists
200 Most Common Drugs (DRG2) Topics Include: Cardiovascular Drugs, Drugs for Thromboembolic Complications, Endocrine Drugs, Diabetes Medications, Thyroid Dysfunction, Adrenal Function, Osteopenia & Osteoporosis, and more.
Instructor Bio
Dr. Geza Terezhalmy, DDS, MA
Biography
Dr. Geza T. Terezhalmy received his D.D.S. degree from Case Western Reserve School of Dental Medicine and his M.A. from The George Washington University. Currently he is a professor for the Department of Comprehensive Dentistry at the University of Texas Health Science Center at the San Antonio Dental School. He is also a clinical professor for the Department of Pharmacology at the Graduate School of Biomedical Sciences at the University of Texas Health Science Center at the San Antonio Dental School. Dr. Terezhalmy serves as a National Consultant for Dental Pharmacotherapeutics to the US Surgeon General and also to the Naval Postgraduate Dental School as a consultant in their department of Oral Medicine. He has served on the editorial boards of Quintessence International, Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology and has an extensive list of publication credits with articles appearing in The American Journal of Dentistry, The International Journal of Dental Hygiene, the Journal of Contemporary Dental Practice and the Archives of Oral Biology. Dr. Terezhalmy has served as president of the Organization of Teachers of Oral Diagnosis and of the American Academy of Oral Medicine.
Conflict of Interest Disclosure: None reported
Topics
Introduction/Overview
Cardiovascular Drugs Cardiovascular Drugs
Drugs for Hypertention
Drugs for Coronary Artery
Drugs for Cardiac Arrhythmias
Drugs for Heart Failure
Drugs for Thromboembolic Complications
Treatment Strategies
Endocrine Drugs Diabetes Medications Drugs for Thyroid Dysfunction Drugs for Adrenal Function Drugs for Osteopenia & Osteoporosis
Diabetes Medications
Drugs for Thyroid Dysfunction
Drugs for Adrenal Function
Drugs for Osteopenia & Osteoporosis
Course Objectives
Today’s clinicians treat more medically and pharmacologically compromised patients than ever before. The availability of more than a thousand active ingredients in several thousand different formulations, and with over 100,000 nonprescription medications, with hundreds of facts about each of them, presents a seemingly insurmountable challenge in mastering the essentials for the clinical decision making process. Fortunately, the clinician who understands general pharmacological principles can learn to predict the behavior of each drug based on a few facts. It is better to develop a drug profile than it is to memorize isolated data. The best way to achieve this objective is to associate, envision, predict, and inquire.
GENERAL OBJECTIVES
Participants in this course will be introduced to representative cardiovascular drug profiles based on the top 200 drugs dispensed by U.S. community pharmacies. An awareness of the various drugs commonly prescribed drugs will assist clinicians in identifying patients with commonly encountered cardiovascular problems. The intent is to provide participants with evidence-based knowledge essential for risk stratification of patients taking cardiovascular drugs and the development of appropriate diagnostic, preventive, and therapeutic strategies commensurate with a patient’s ability to undergo and respond to dental care.
LEARNING OUTCOMES
After completing this course the participant will have a better understanding and working knowledge of the following:
Evidence-based knowledge essential for risk stratifications of patients taking one of 200 drugs dispensed by United States community pharmacies and for the developing oral healthcare strategies commensurate with patients’ functional capacity.
Accreditation
American Seminar Institute is an approved provider of ADA-CERP, AGD-PACE and the California Board of Dental Examiners.
Produced: 5/25/2018 Expires for ADA/AGD Credit: 5/24/2021
Additional Information
Additional Dental Continuing Education (CE/CPD) options available:
Other courses of interest may include: Foundations in Pediatric Dentistry, Conquering Difficult Cases, Head and Neck Cancer and Orofacial Pain and Temporomandibular Disorder
For up-coming courses, please visit: Dental Courses Coming Soon. There you will find abbreviated listings of additional courses that are soon to be released.